Annals of Pediatric Endocrinology & Metabolism


Long-term outcomes of Graves’ disease in children and adolescents receiving antithyroid drugs: Jung Gi Rho, Change Dae Kum, Young Jun Seo, Young Suk Shim, Hae Sang Lee, Jin Soon Hwang; Ann Pediatr Endocrinol Metab. 2021;26(4):266-271. Published online May 20, 2021; DOI: https://doi.org/10.6065/apem.2040286.143
Web of Science 4 Crossref 3; Full text PubReader ePub PDF


Features of partial remission in children with type 1 diabetes using the insulin dose-adjusted A1c definition and risk factors associated with nonremission: Tsz Wai Catherine Wong, Man Yee Shirley Wong, Wai Man Betty But; Ann Pediatr Endocrinol Metab. 2021;26(2):118-125. Published online June 30, 2021; DOI: https://doi.org/10.6065/apem.2040202.101
Web of Science 8 Crossref 10; Full text PubReader ePub PDF Supplementary Material


The Clinical Course and Prognostic Factors to Medical Treatment of Graves' Disease in Children and Adolescents.: Wun Kon Kim, Byung Hoon Ahn, Heon Seok Han; Ann Pediatr Endocrinol Metab. 2012;17(1):33-38.; DOI: https://doi.org/10.6065/apem.2012.17.1.33
Crossref 3; PDF

Search